Triple negative breast cancer: nanosolutions for a big challenge

Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer that lacks expression of estrogen and progesterone receptors (ER/PR) and amplification of the human epidermal growth factor receptor 2 (HER2) gene. Characterized by aggressive and metastatic phenotypes a...

Full description

Bibliographic Details
Main Author: Mendes, T. (author)
Other Authors: Kluskens, Leon (author), Rodrigues, L. R. (author)
Format: article
Language:eng
Published: 2015
Subjects:
nanotechnology
drug delivery
diagnostics
cancer therapy
triple negative breast cancer (TNBC)
Science & Technology
Online Access:http://hdl.handle.net/1822/38393
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/38393

Internet

http://hdl.handle.net/1822/38393

Similar Items